Principal Investigator
Corneliu Luca
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220778
Clinical Trial Summary
A double-blind, placebo-controlled, randomized, Phase 2a study with oral UCB0599 in study participants with early Parkinson's disease
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Lissette Perez
Phone Number
+1 (305) 2432172
Email
lperez4@miami.edu